A novel anticancer diterpenoid from Jatropha gossypifolia
Abiodun Falodun1, Udo Kragl, Serge-Mitherand Tengho Touem
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, Nigeria, Edo State 30001. faloabi@uniben.edu
Natural Product Communications
|April 6, 2012
Summary
Jatropha gossypifolia root bark yielded a novel anticancer compound, abiodone. This lathyrane diterpenoid shows potential for treating bacterial infections and lung cancer.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Medicinal Chemistry
Background:
- Jatropha gossypifolia root bark is traditionally used to treat bacterial infections and lung cancer.
- Ethnomedicinal uses suggest the presence of bioactive compounds within the plant.
- Identifying novel compounds from medicinal plants can lead to new therapeutic agents.
Purpose of the Study:
- To isolate and characterize bioactive compounds from Jatropha gossypifolia root bark.
- To identify novel chemical structures with potential anticancer activity.
- To elucidate the structure of a newly discovered lathyrane diterpenoid.
Main Methods:
- Phytochemical investigation of Jatropha gossypifolia root bark extract.
- Isolation and purification of compounds using chromatographic techniques.
- Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
- Confirmation of molecular structure via X-ray crystallographic analysis.
Main Results:
- Isolation and characterization of a novel lathyrane diterpenoid, named abiodone.
- Abiodone possesses an unusual methylene group within its structure.
- The compound demonstrated potent anticancer activity in preliminary assessments.
- The structure was unambiguously determined through comprehensive spectroscopic and crystallographic data.
Conclusions:
- Abiodone is a novel lathyrane diterpenoid isolated from Jatropha gossypifolia.
- The unique structure of abiodone contributes to its potent anticancer properties.
- This discovery supports the ethnomedicinal use of Jatropha gossypifolia and offers a new lead for cancer drug development.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...